ArticleDrug delivery and translational research2019

Easy formulation of liposomal doxorubicin modified with a bombesin peptide analogue for selective targeting of GRP receptors overexpressed by cancer cells.

Antonella Accardo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.